Clinical Trial Detail

NCT ID NCT02065687
Title Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Gynecologic Oncology Group
Indications

endometrial clear cell adenocarcinoma

endometrial carcinoma

endometrial adenocarcinoma

Therapies

Carboplatin + Metformin + Paclitaxel

Carboplatin + Paclitaxel

Age Groups: senior adult

No variant requirements are available.